Abstract
BackgroundSystemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by autoantibody production and multisystem inflammation. Alpha-adrenoceptor blockers(AAB), angiotensin converting enzyme inhibitors(ACEI), beta-adrenoceptor blockers(BB) and calcium channel blockers(CCB) are...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
